Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 27432875

Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2016 Sep 22
First author
Chen R

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2016 Sep 22;128(12):1540-1. doi: 10.1182/blood-2016-08-730374.
    note
    Source null
    related pmid
    27658697
    relationship
    Comment in

Authors and identifiers

  1. name
    Chen R
    type
    Author
  2. name
    Gopal AK
    type
    Author
  3. name
    Smith SE
    type
    Author
  4. name
    Ansell SM
    type
    Author
  5. name
    Rosenblatt JD
    type
    Author
  6. name
    Savage KJ
    type
    Author
  7. name
    Connors JM
    type
    Author
  8. name
    Engert A
    type
    Author
  9. name
    Larsen EK
    type
    Author
  10. name
    Huebner D
    type
    Author
  11. name
    Fong A
    type
    Author
  12. name
    Younes A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Chen R
    type
    Author
  2. name
    Gopal AK
    type
    Author
  3. name
    Smith SE
    type
    Author
  4. name
    Ansell SM
    type
    Author
  5. name
    Rosenblatt JD
    type
    Author
  6. name
    Savage KJ
    type
    Author
  7. name
    Connors JM
    type
    Author
  8. name
    Engert A
    type
    Author
  9. name
    Larsen EK
    type
    Author
  10. name
    Huebner D
    type
    Author
  11. name
    Fong A
    type
    Author
  12. name
    Younes A
    type
    Author
bibliography ids
  1. nci-bib-667a5ff639152c49151d430f
book metadata
content sha256
56dd893a37fb3e12749019ef6ef8bdad015e93985ea9f717ba0805a276be7e2f
document type
citation
dois
  1. 10.1182/blood-2016-02-699850
electronic publication date
display
2016 Jul 18
precision
day
year
2016
evidence scope
bibliographic_metadata_only
id
pubmed:27432875
immutable id
pubmed:27432875@56dd893a37fb3e12749019ef6ef8bdad015e93985ea9f717ba0805a276be7e2f
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
12
name
Blood
nlm unique id
7603509
pages
1562-6
volume
128
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2016 Sep 22;128(12):1540-1. doi: 10.1182/blood-2016-08-730374.
    note
    Source null
    related pmid
    27658697
    relationship
    Comment in
outcomes validated
false
pmid
27432875
provenance
batch id
d649bcb2d98dbbacd53c
provider
NCBI PubMed ESummary
record sha256
536170a7ce2205d004f11737cb300ee737cd8524a2d4e4b71ce2dff646420bf6
response sha256
26648a40f123f366675007f51cc29befd1f9a89273ca2da87c477c54d2d15d20
retrieved at
2026-09-09T23:47:20.761544+00:00
publication date
display
2016 Sep 22
precision
day
year
2016
publication types
  1. Journal Article
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/27432875/
title
Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma.

Preserved source evidence · Not medical advice